143 related articles for article (PubMed ID: 8789697)
1. Lidocaine elimination and monoethylglycinexylidide formation in the dehydrated camel.
Ben-Zvi Z; Goldin G; Van Creveld C; Yagil R
J Vet Pharmacol Ther; 1995 Dec; 18(6):442-5. PubMed ID: 8789697
[TBL] [Abstract][Full Text] [Related]
2. Antipyrine disposition in the dehydrated camel.
Ben-Zvi Z; Rubin M; Van Creveld C; Yagil R
J Vet Pharmacol Ther; 1995 Apr; 18(2):137-40. PubMed ID: 7629928
[TBL] [Abstract][Full Text] [Related]
3. [Lidocaine metabolism associated with epidural anesthesia in patients for hepatic surgery].
Sato T; Ono T; Ozaki M; Sakio H; Yasuda S
Masui; 1999 Dec; 48(12):1318-22. PubMed ID: 10658411
[TBL] [Abstract][Full Text] [Related]
4. Endotoxic shock alters the pharmacokinetics of lidocaine and monoethylglycinexylidide.
McKindley DS; Boulet J; Sachdeva K; Wang P; Chichester C
Shock; 2002 Mar; 17(3):199-204. PubMed ID: 11900338
[TBL] [Abstract][Full Text] [Related]
5. Effect of phenobarbital on the pharmacokinetics of lidocaine, monoethylglycinexylidide and 3-hydroxylidocaine in the rat: correlation with P450 isoform levels.
Nakamoto T; Oda Y; Imaoka S; Funae Y; Fujimori M
Drug Metab Dispos; 1997 Mar; 25(3):296-300. PubMed ID: 9172946
[TBL] [Abstract][Full Text] [Related]
6. Formation of monoethylglycinexylidide (MEGX) in clinically healthy dogs.
Neumann S; Frenz M; Streit F; Oellerich M
Can J Vet Res; 2011 Oct; 75(4):317-20. PubMed ID: 22468031
[TBL] [Abstract][Full Text] [Related]
7. The MEGX test: a tool for the real-time assessment of hepatic function.
Oellerich M; Armstrong VW
Ther Drug Monit; 2001 Apr; 23(2):81-92. PubMed ID: 11294522
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of lidocaine and its active metabolite monoethylglycinexylidide after a single intravenous administration in chickens (Gallus domesticus) anesthetized with isoflurane.
Da Cunha AF; Messenger KM; Stout RW; Barker SA; Nevarez JG; Queiroz-Williams P; Tully TN
J Vet Pharmacol Ther; 2012 Dec; 35(6):604-7. PubMed ID: 22212047
[No Abstract] [Full Text] [Related]
9. Effect of itraconazole on the pharmacokinetics of inhaled lidocaine.
Isohanni MH; Neuvonen PJ; Olkkola KT
Basic Clin Pharmacol Toxicol; 2004 Sep; 95(3):120-3. PubMed ID: 15447735
[TBL] [Abstract][Full Text] [Related]
10. Effect of ciprofloxin on the pharmacokinetics of intravenous lidocaine.
Isohanni MH; Ahonen J; Neuvonen PJ; Olkkola KT
Eur J Anaesthesiol; 2005 Oct; 22(10):795-9. PubMed ID: 16211753
[TBL] [Abstract][Full Text] [Related]
11. Monoethylglycinexylidide formation kinetics: a novel approach to assessment of liver function.
Oellerich M; Raude E; Burdelski M; Schulz M; Schmidt FW; Ringe B; Lamesch P; Pichlmayr R; Raith H; Scheruhn M
J Clin Chem Clin Biochem; 1987 Dec; 25(12):845-53. PubMed ID: 3443824
[TBL] [Abstract][Full Text] [Related]
12. [Serum concentration of lidocaine and its active metabolite monoethylglycinexylidine during fiberoptic bronchoscopy under local anesthesia].
Milman N; Laub MS; Munch EP; Angelo HR
Ugeskr Laeger; 1991 Mar; 153(13):932-5. PubMed ID: 2024301
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function.
Orlando R; Piccoli P; De Martin S; Padrini R; Floreani M; Palatini P
Clin Pharmacol Ther; 2004 Jan; 75(1):80-8. PubMed ID: 14749694
[TBL] [Abstract][Full Text] [Related]
14. Effect of experimental diabetes on pharmacokinetic parameters of lidocaine and MEGX in rats.
Gawrońska-Szklarz B; Musiał DH; Pawlik A; Paprota B
Pol J Pharmacol; 2003; 55(4):619-24. PubMed ID: 14581721
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of lidocaine and its metabolite in peridural anesthesia administered to pregnant women with gestational diabetes mellitus.
Moisés EC; Duarte Lde B; Cavalli Rde C; Marques MP; Lanchote VL; Duarte G; da Cunha SP
Eur J Clin Pharmacol; 2008 Dec; 64(12):1189-96. PubMed ID: 18679666
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of lidocaine by purified rat liver microsomal cytochrome P-450 isozymes.
Oda Y; Imaoka S; Nakahira Y; Asada A; Fujimori M; Fujita S; Funae Y
Biochem Pharmacol; 1989 Dec; 38(24):4439-44. PubMed ID: 2604746
[TBL] [Abstract][Full Text] [Related]
17. Effect of 4% topical lidocaine applied to the face on the serum levels of lidocaine and its metabolite, monoethylglycinexylidide.
Oni G; Brown S; Burrus C; Grant L; Watkins J; Kenkel M; Barton F; Kenkel J
Aesthet Surg J; 2010; 30(6):853-8. PubMed ID: 21131461
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of lidocaine and its active metabolite, monoethylglycinexylidide, after intravenous administration of lidocaine to awake and isoflurane-anesthetized cats.
Thomasy SM; Pypendop BH; Ilkiw JE; Stanley SD
Am J Vet Res; 2005 Jul; 66(7):1162-6. PubMed ID: 16111153
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of lidocaine following the application of 5% lidocaine patches to cats.
Ko JC; Maxwell LK; Abbo LA; Weil AB
J Vet Pharmacol Ther; 2008 Aug; 31(4):359-67. PubMed ID: 18638297
[TBL] [Abstract][Full Text] [Related]
20. The monoethylglycinexylidide test does not correctly evaluate lidocaine metabolism after ischemic liver injury in the rat.
Leclercq I; Saliez A; Wallemacq PE; Horsmans Y; Lambotte L
Hepatology; 1997 Nov; 26(5):1182-8. PubMed ID: 9362360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
